MarketInOut Stock Screener Log In | Sign Up

GC Cell Corp

KRX • Healthcare • Diagnostics & Research • Quote as of 10/28/2026 15:30
GC Cell Corp stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeKRX
Market Capitalization199,560 mln
Float7.88 mln
Earnings Date08/18/2025

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-6.36
Highly reliable

Relative Strength

2 / 100
Severely lagging

Debt / Equity

0.58
Moderate leverage

Pre-Tax Margin

-143%
Severely loss-making

ROE

-84.49
Deeply negative

Business Description

GC Cell Corporation is a South Korean biotechnology company founded in 2011 and headquartered in Yongin-si, specializing in the development and commercialization of cell-based treatments, with its flagship product being Immuncell-LC. Beyond its core research activities, the company offers a range of supporting services including cell storage, sample testing, clinical trials management, and biological logistics. GC Cell also works alongside Lukas Biomedical Co. Ltd. under a strategic partnership to advance cell therapy development.

Key Fundamentals

EPS-16,397
ROE-84.49
RPS10,780
ROIC-2.73
ROA-56.98
EBITDA, mln-212,232
EV / EBITDA-1.51
EV / EBIT-1.41
Revenue, mln161,997
EV / Revenue1.98

Quote Details

Last 10,470
Change -2480 (-19.15%)
Open 11,730
Volume 314,547
Turnover 3,293,307,136
Average Volume 38,463

Financial Ratios

Pre-Tax Profit Margin-143
Current Ratio0.52
Price / Book1.11
Price / Tangible Book3.78
Price / Free Cash Flow57.69
Debt / Equity0.58
Price / Sales1.30

Financial Strength

Altman Z-Score-0.41
Piotroski F-Score 5 / 9
Beneish M-Score-6.36
Price to Intrinsic Value0.93

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -24.62% 0 / 100   
1 Month -25.48% 5 / 100   
2 Months -21.51% 12 / 100   
6 Months -58.62% 6 / 100   
1 Year -48.17% 13 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog